Live Breaking News & Updates on Full Approval Of Sotorasib

Stay updated with breaking news from Full approval of sotorasib. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA Issues Complete Response Letter to Sotorasib for KRAS G12C–Mutated NSCLC

The FDA has issued a complete response letter to the supplemental new drug application seeking the full approval of sotorasib for patients with KRAS G12C–mutated non–small cell lung cancer. ....

United States , Full Approval Of Sotorasib , Patients With Kras G12c Mutated Non Small Cell Lung Cancer , Codebreak 200 Trial , Codebreak 100 Trial ,